New search | Conferencedetail
mail
Print view
 
 

13th Process Development for Highly Potent Drugs Summit (HPAPI)

Evvnt Promotion / evvnt
-
25.06.2024 - 27.06.2024  Delta Hotel Philadelphia Airport, 500 Stevens Drive, 19113 Philadelphia, Pennsylvania, USA
Time: 1:30 PM - 3:45 PM
 
Conference themes
From Process Safety to Rapid Scale-Up to Tech Transfer: Integrating Process Development, Industrial Hygiene and Equipment Selection to Achieve GMP Manufacturing of Novel High Potent Drug Compounds 2023 has been a pivotal year for novel high potent compounds securing early success and approvals – from Henlius’s ADC to Gilead’s Trodelvy to BMS’s Augtyro, cementing the growth of highly potent drugs market to reach USD$40.7bn by 2023.
Professional congress organizer (PCO)
Hanson Wade Group
Notes
URL:
Brochure: https://go.evvnt.com/2316046-3?pid=4832

Speakers: Antonio Hernandez-Cardoso, Senior Principal Scientist, US Pharmacopiea, and more
 

Enquiries and Registration:

https://go.evvnt.com/2316046-2?pid=4832
Ms. Gracia Carr
 
Categories
General Medicine
Languages
English
Congress fees
USD 2599.00 - USD 5197.00
Participants expected
1000 - 1000
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

AGEM - Arbeitsgemeinschaft Ethnologie und MedizinCharité International AcademyHelix - Forschung & Beratung WienÖsterreichisches Rotes KreuzHilfswerk AustriaÖsterreichische Akademie der ÄrzteOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Ärzte der Welt